NCT00992446 2020-03-18Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin LymphomaFred Hutchinson Cancer CenterPhase 2 Completed27 enrolled 13 charts
NCT00703664 2018-08-07Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell LymphomaNational Cancer Institute (NCI)Phase 2 Completed65 enrolled 14 charts
NCT01789255 2018-07-24Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesNational Cancer Institute (NCI)Phase 2 Completed12 enrolled 11 charts